NO20041955L - Monohydroksylkarbamazepin for anvendelse ved fremstillingen av et medikament for affektive lidelser eller oppmerksomhetsforstyrrelser og neuropatisk smerte - Google Patents

Monohydroksylkarbamazepin for anvendelse ved fremstillingen av et medikament for affektive lidelser eller oppmerksomhetsforstyrrelser og neuropatisk smerte

Info

Publication number
NO20041955L
NO20041955L NO20041955A NO20041955A NO20041955L NO 20041955 L NO20041955 L NO 20041955L NO 20041955 A NO20041955 A NO 20041955A NO 20041955 A NO20041955 A NO 20041955A NO 20041955 L NO20041955 L NO 20041955L
Authority
NO
Norway
Prior art keywords
disorders
monohydroxylcarbamazepine
drug
manufacture
neuropathic pain
Prior art date
Application number
NO20041955A
Other languages
English (en)
Norwegian (no)
Inventor
Markus Schmutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0127177A external-priority patent/GB0127177D0/en
Priority claimed from GB0127178A external-priority patent/GB0127178D0/en
Priority claimed from GB0127176A external-priority patent/GB0127176D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20041955L publication Critical patent/NO20041955L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20041955A 2001-11-12 2004-05-12 Monohydroksylkarbamazepin for anvendelse ved fremstillingen av et medikament for affektive lidelser eller oppmerksomhetsforstyrrelser og neuropatisk smerte NO20041955L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0127177A GB0127177D0 (en) 2001-11-12 2001-11-12 Organic compounds
GB0127178A GB0127178D0 (en) 2001-11-12 2001-11-12 Organic compounds
GB0127176A GB0127176D0 (en) 2001-11-12 2001-11-12 Organic compounds
PCT/EP2002/012578 WO2003042182A1 (en) 2001-11-12 2002-11-11 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain

Publications (1)

Publication Number Publication Date
NO20041955L true NO20041955L (no) 2004-05-12

Family

ID=27256320

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041955A NO20041955L (no) 2001-11-12 2004-05-12 Monohydroksylkarbamazepin for anvendelse ved fremstillingen av et medikament for affektive lidelser eller oppmerksomhetsforstyrrelser og neuropatisk smerte

Country Status (20)

Country Link
US (1) US20050004102A1 (de)
EP (2) EP1446383B1 (de)
JP (1) JP2005511623A (de)
KR (1) KR20050044396A (de)
CN (1) CN100506797C (de)
AT (1) ATE408602T1 (de)
AU (2) AU2007201925B2 (de)
BR (1) BR0214060A (de)
CA (1) CA2463970A1 (de)
DE (1) DE60228988D1 (de)
ES (1) ES2314111T3 (de)
HU (1) HUP0402381A3 (de)
IL (1) IL161700A0 (de)
MX (1) MXPA04004470A (de)
NO (1) NO20041955L (de)
NZ (1) NZ556026A (de)
PL (1) PL368591A1 (de)
PT (1) PT1446383E (de)
TW (1) TW200300090A (de)
WO (1) WO2003042182A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0407569A (pt) * 2003-02-17 2006-02-14 Novartis Ag uso de s-10-hidróxi-10, 11-diidro-carbamazepina para o tratamento de ansiendade e distúrbios bipolares
GB0303615D0 (en) * 2003-02-17 2003-03-19 Novartis Ag Use of organic compounds
TW200502222A (en) * 2003-04-02 2005-01-16 Novartis Ag Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
GB0307860D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Organic compounds
PT2380575E (pt) * 2005-05-06 2015-06-17 Bial Portela & Ca Sa Acetato de eslicarbazepina e utilização
US20060252745A1 (en) * 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0603008D0 (en) * 2006-02-14 2006-03-29 Portela & Ca Sa Method
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505101A (de) * 1969-03-31 1971-03-31 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
DK74593D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso

Also Published As

Publication number Publication date
HUP0402381A3 (en) 2008-01-28
DE60228988D1 (de) 2008-10-30
EP1446383B1 (de) 2008-09-17
HK1068350A1 (en) 2005-04-29
TW200300090A (en) 2003-05-16
CN100506797C (zh) 2009-07-01
HUP0402381A2 (hu) 2005-03-29
AU2007201925A1 (en) 2007-05-24
EP2048135A1 (de) 2009-04-15
NZ556026A (en) 2008-06-30
AU2007201925B2 (en) 2009-06-04
IL161700A0 (en) 2004-09-27
US20050004102A1 (en) 2005-01-06
MXPA04004470A (es) 2005-05-16
PT1446383E (pt) 2008-12-29
EP1446383A1 (de) 2004-08-18
CA2463970A1 (en) 2003-05-22
ATE408602T1 (de) 2008-10-15
AU2009201388A1 (en) 2009-05-07
KR20050044396A (ko) 2005-05-12
BR0214060A (pt) 2004-10-13
ES2314111T3 (es) 2009-03-16
PL368591A1 (en) 2005-04-04
CN1585753A (zh) 2005-02-23
JP2005511623A (ja) 2005-04-28
WO2003042182A1 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
DE60230869D1 (de) 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
ATE381347T1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
ATE427114T1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen
NO20041588L (no) Anvendelse av flibanserin ved behandling av seksuelle forstyrrelser
IS7203A (is) 4[píperidín-4-ýliden-(3-karbamólýlfenýl)metýl]bensamíðafleiður og notkun þeirra til að meðhöndla verki, mænuskaða eða maga- og garnasjúkdóma
NO20033123L (no) Terapeutisk hinne dannende sammensetning og behandlingsplan derav
ATE303379T1 (de) 4-(phenyl-piperidin-4-ylidenmethyl)-benzamid- derivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
NO20052698D0 (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
NO20041955L (no) Monohydroksylkarbamazepin for anvendelse ved fremstillingen av et medikament for affektive lidelser eller oppmerksomhetsforstyrrelser og neuropatisk smerte
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
NO20006506D0 (no) Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
NO20023448D0 (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
NO20052699D0 (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
IL158703A0 (en) 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
DE60314003D1 (de) 4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen
DE60213234D1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts
DE60202684D1 (de) Pflanzenpräparat zur behandlung und heilung von bronchialen respiratorischen schwierigkeiten
DE60202679D1 (de) 4-(phenylpiperidin-4-ylidenmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
DE60208192D1 (de) 4-(phenyl(piperidin-4-yl)amino) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
IL164779A0 (en) Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other oculat disorders
EP1330271A4 (de) Verwendung von transkriptionsfaktoren zur behandlung von entzündungen und anderen erkrankungen
DE60208193D1 (de) 4-(phenyl(piperidin-4-yl)amino) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
NO20014180L (no) Anvendelse av fluorinerte triazoler til behandling av smerte og smertefulle lidelser eller oppmerksomhetshunger
NO20042166L (no) Kombinasjonsterapi for behandling av sykdom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application